| Characterization of therapeutic antibodies and related products A Beck, E Wagner-Rousset, D Ayoub, A Van Dorsselaer, ... Analytical chemistry 85 (2), 715-736, 2013 | 660 | 2013 |
| Poly (ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression C Boehler, LR Gauthier, O Mortusewicz, DS Biard, JM Saliou, A Bresson, ... Proceedings of the National Academy of Sciences 108 (7), 2783-2788, 2011 | 319 | 2011 |
| Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry A Beck, S Sanglier-Cianférani, A Van Dorsselaer Analytical chemistry 84 (11), 4637-4646, 2012 | 304 | 2012 |
| 2-D structure of the A region of Xist RNA and its implication for PRC2 association S Maenner, M Blaud, L Fouillen, A Savoye, V Marchand, A Dubois, ... PLoS biology 8 (1), e1000276, 2010 | 289 | 2010 |
| Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma B Herquel, K Ouararhni, K Khetchoumian, M Ignat, M Teletin, M Mark, ... Proceedings of the National Academy of Sciences 108 (20), 8212-8217, 2011 | 234 | 2011 |
| A sulfenic acid enzyme intermediate is involved in the catalytic mechanism of peptide methionine sulfoxide reductase fromEscherichia coli S Boschi-Muller, S Azza, S Sanglier-Cianferani, F Talfournier, ... Journal of Biological Chemistry 275 (46), 35908-35913, 2000 | 231 | 2000 |
| Innovative native MS methodologies for antibody drug conjugate characterization: high resolution native MS and IM-MS for average DAR and DAR distribution assessment F Debaene, A Boeuf, E Wagner-Rousset, O Colas, D Ayoub, N Corvaia, ... Analytical chemistry 86 (21), 10674-10683, 2014 | 195 | 2014 |
| Adding a new separation dimension to MS and LC–MS: what is the utility of ion mobility spectrometry? V d'Atri, T Causon, O Hernandez‐Alba, A Mutabazi, JL Veuthey, ... Journal of separation science 41 (1), 20-67, 2018 | 178 | 2018 |
| Proline: an efficient and user-friendly software suite for large-scale proteomics D Bouyssié, AM Hesse, E Mouton-Barbosa, M Rompais, C Macron, ... Bioinformatics 36 (10), 3148-3155, 2020 | 177 | 2020 |
| Aβ (1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage S Ciudad, E Puig, T Botzanowski, M Meigooni, AS Arango, J Do, ... Nature communications 11 (1), 3014, 2020 | 149 | 2020 |
| Analytical characterization of biosimilar antibodies and Fc-fusion proteins A Beck, H Diemer, D Ayoub, F Debaene, E Wagner-Rousset, C Carapito, ... TrAC Trends in Analytical Chemistry 48, 81-95, 2013 | 149 | 2013 |
| Cutting‐edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies A Beck, F Debaene, H Diemer, E Wagner‐Rousset, O Colas, ... Journal of Mass Spectrometry 50 (2), 285-297, 2015 | 144 | 2015 |
| Characterization of the methionine sulfoxide reductase activities of PILB, a probable virulence factor from Neisseria meningitidis A Olry, S Boschi-Muller, M Marraud, S Sanglier-Cianferani, ... Journal of Biological Chemistry 277 (14), 12016-12022, 2002 | 143 | 2002 |
| A novel mechano‐enzymatic cleavage mechanism underlies transthyretin amyloidogenesis J Marcoux, PP Mangione, R Porcari, MT Degiacomi, G Verona, GW Taylor, ... EMBO molecular medicine 7 (10), 1337-1349, 2015 | 142 | 2015 |
| Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine‐linked antibody drug conjugate J Marcoux, T Champion, O Colas, E Wagner‐Rousset, N Corvaïa, ... Protein Science 24 (8), 1210-1223, 2015 | 138 | 2015 |
| Physiologically relevant reconstitution of iron-sulfur cluster biosynthesis uncovers persulfide-processing functions of ferredoxin-2 and frataxin S Gervason, D Larkem, AB Mansour, T Botzanowski, CS Müller, ... Nature communications 10 (1), 3566, 2019 | 128 | 2019 |
| Simultaneous Self‐Assembly of a [2] Catenane, a Trefoil Knot, and a Solomon Link From a Simple Pair of Ligands T Prakasam, M Lusi, M Elhabiri, C Platas‐Iglesias, JC Olsen, Z Asfari, ... Angewandte Chemie 125 (38), 10140-10144, 2013 | 112 | 2013 |
| Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates A Beck, G Terral, F Debaene, E Wagner-Rousset, J Marcoux, ... Expert review of proteomics 13 (2), 157-183, 2016 | 109 | 2016 |
| Native MS: An’ESI ‚way to support structure-and fragment-based drug discovery V Vivat Hannah, C Atmanene, D Zeyer, A Van Dorsselaer, ... Future medicinal chemistry 2 (1), 35-50, 2010 | 104 | 2010 |
| An online four-dimensional HIC× SEC-IM× MS methodology for proof-of-concept characterization of antibody drug conjugates A Ehkirch, V d’Atri, F Rouviere, O Hernandez-Alba, A Goyon, O Colas, ... Analytical chemistry 90 (3), 1578-1586, 2018 | 97 | 2018 |
